• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza B virus infection and Stevens-Johnson syndrome

tetano

Editor, Senior Moderator
Pediatr Dermatol. 2017 Dec 28. doi: 10.1111/pde.13370. [Epub ahead of print]
[h=1]Influenza B virus infection and Stevens-Johnson syndrome.[/h] Tamez RL[SUP]1[/SUP], Tan WV[SUP]2[/SUP], O'Malley JT[SUP]3[/SUP], Broder KR[SUP]4[/SUP], Garzon MC[SUP]2,[/SUP][SUP]5[/SUP], LaRussa P[SUP]5[/SUP], Lauren CT[SUP]2,[/SUP][SUP]5[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] A 2-year-old boy with influenza B infection and rapidly worsening targetoid skin lesions with mucosal involvement was diagnosed with Stevens-Johnson syndrome (SJS) and treated with oseltamivir and intravenous immunoglobulin, with resolution of illness. Subsequent quadrivalent inactivated influenza vaccine was well tolerated. This case highlights the rarity of SJS in the setting of influenza B infection and addresses the safety of administering subsequent influenza vaccines to such individuals.


[h=4]KEYWORDS:[/h] influenza vaccine; intravenous immunoglobulin; vaccine safety

PMID: 29282756 DOI: 10.1111/pde.13370
 
Back
Top Bottom